Physician

Luke Eastburg, MD

According to 2025 Medicare claims, Luke Eastburg, MD (NPI: 1649626508) practices hematology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 49546-2379.

Eastburg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 103 traditional Medicare patients, billed 15,016 HCPCS/CPT codes, and received $283,215 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 125 prescription claims across 36 beneficiaries totaling $147,633 in drug costs, led by Hydroxyurea (Hydroxyurea). 2018 DME data shows 11 claims. Open Payments data shows 5 records totaling $215. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $554 and ending at $147,633. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$142K$283K2020 Medicare payment: $5,480 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,648 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $283,215 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201964$5,480
20212059$4,648
2022N/RN/RN/R
2023N/RN/RN/R
202410315,016$283,215

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$74K$148K2016 Drug cost: $554 (USD; Tot_Drug_Cst)2017 Drug cost: $23,538 (USD; Tot_Drug_Cst)2018 Drug cost: $19,610 (USD; Tot_Drug_Cst)2019 Drug cost: $4,416 (USD; Tot_Drug_Cst)2020 Drug cost: $5,970 (USD; Tot_Drug_Cst)2021 Drug cost: $57,538 (USD; Tot_Drug_Cst)2022 Drug cost: $5,544 (USD; Tot_Drug_Cst)2024 Drug cost: $147,633 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161537$554
201720109$23,538
20181390$19,610
20191984$4,416
20201637$5,970
20212766$57,538
2022N/R28$5,544
2023N/RN/RN/R
202436125$147,633

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$417$8352018 Medicare payment: $835 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R11$835
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2635$90
82728Ferritin (blood protein) level2125$13
80053Blood test, comprehensive group of blood chemicals3045$10
36415Insertion of needle into vein for collection of blood sample3799$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3798$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
HydroxyureaHydroxyurea311,554$965
Morphine Sulfate ErMorphine Sulfate16456$697

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$215GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Luke Eastburg, MD?

Tedicare shows public-source Medicare data for Luke Eastburg, MD (NPI 1649626508), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Luke Eastburg, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Luke Eastburg, MD?

Luke Eastburg, MD is linked to CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (billing NPI 1528018389) in the available physician profile data.

Does Luke Eastburg, MD have Open Payments data?

Luke Eastburg, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.